SPAC stocks like Rising Dragon Acquisition surged nearly 47% amid volatility, while biotech firm bioAffinity Technologies jumped 44% after a reverse stock split. Renewable energy company Fervo Energy gained 28% following a major geothermal power deal with Google. AI infrastructure firm Corvex and leveraged ETFs tied to Moderna also posted strong gains, reflecting sector-specific developments and market momentum.
Moderna's stock jumped 6% even as GSK moved its mRNA-based flu vaccine into Phase III trials, signaling strong confidence in mRNA technology beyond direct competition. GSK's vaccine showed promising immune responses in mid-stage trials and targets bo...
In August, stocks that had been hit by bearish fears, especially in enterprise software, staged a strong comeback. Companies like Moderna surged after positive vaccine news, while Palantir, Veeva, Salesforce, and ServiceNow recovered as concerns abou...
BioNTech halted its Phase 2 trial for a colorectal cancer vaccine after a Data Safety Monitoring Board found no efficacy, causing its stock to fall 8%. This setback also pressured Moderna's shares, which dropped 6%, despite its recent melanoma vaccin...
